Comments on: TYK2 Inhibitor Shows Promise for Moderate-to-Severe Psoriasis https://plasticsurgerypractice.com/client-objectives/dermatology/skin-conditions/tyk2-inhibitor-shows-promise-moderate-severe-psoriasis/ Plastic Surgery Practice is the brand that 12,000 plastic surgeons rely on for the latest information on the clinical innovations, practice-management trends, emerging products and technologies, and news stories that drive their field. With well-thought-out articles by leading practitioners, PSP gets to the core of the most complex issues in plastic surgery, including controversial new treatments, the use of highly technical equipment, and physician-patient interactions. Wed, 19 Mar 2025 12:23:39 +0000 hourly 1 https://wordpress.org/?v=6.7.2